CL
Insider
Corvex Management LP
DirectorCorvex Management LP (Director) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in GeneDx Holdings Corp. (WGS). Across 1 priced purchase filing, the average 21-session return was +8.9% from execution and +3.1% from disclosure (delay-adjusted; derived). The largest single filing was $3.0M of WGS (50,000 sh across 2 lots, as filed), executed May 14 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+8.9%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+3.1%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.0M
shares × price, as filed
Last traded
May 14 2025
Filed May 16 2025
Median ADV $82.7M across their filed names
Open performance→Volume by month
Buys $3.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
WGSRecent filings
WGSPURCHASE
GeneDx Holdings Corp.
View filing →
$3.0M50,000 sh across 2 lots
Exec May 14 2025
Filed May 16 2025 · 5:30 PM ET